Raybow PharmaScience brings client projects from medchem to commercial launch and has developed client NCE’s from Candidate to current blockbuster status (USD$1Bill. in prescription sales).
We are motivated by creating solutions to solve our client’s chemical development challenges in order to get new small molecule drugs to market successfully, efficiently and sustainably. In 2023 we celebrate 50 years of continuous supply to the pharma community.
Our services includes:
- First scale-up from mg to gram, non-GMP research batches, partial process development, formulation development, full process development and commercial scale production.
- Peptides, OEL 1 – 5, Chiral
- On time, on budget, on quality – also during Covid!
Our Corporate Profile is to work actively for introducing more Sustainable Chemistry and achieve the goals for carbon, water and plastic according to the UN Global Compact.
Read more at www.Raybow.com